Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity

doi:10.4254/wjh.v14.i6.1099

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3526)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

226

WORD

HTML

1698

Figures (1-2)

432

Tables (1-1)

342

Sum=2779

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

277

Download

470

Sum=747

Jun 27, 2022 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jun 27, 2022; 14(6): 1099-1110
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1099

Full Size Figure Download Figure

Figure 2 Associated factors for liver disease progression and its management strategies in patients with coronavirus disease 19. CLD: Chronic liver disease; NAFLD: Non-alcoholic fatty liver disease; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyltransferase; DBIL: Direct bilirubin. Created with BioRender.com.

Citation: Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110
URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1099.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1099